Rompun Inj 20mg/mL 20 mg Liquid is a Health Canada–registered veterinary drug (DIN 00408972) held by Bayvet, Division Of Chemagro Ltd., containing Xylazine Hydrochloride. Health Canada lists its status as Cancelled Post Market (status date 09 Sep 1996). Nexara Health has matched 6 registrations of Xylazine Hydrochloride across 2 other regulated markets.
Health Canada registration
| DIN | 00408972 |
|---|---|
| Brand name | Rompun Inj 20mg/mL |
| Active ingredient | Xylazine Hydrochloride |
| Strength | 20 mg |
| Dosage form | Liquid |
| Route | Intramuscular ; Intravenous ; Subcutaneous |
| Company | Bayvet, Division Of Chemagro Ltd. |
| Status | Cancelled Post Market — 09 Sep 1996 |
| Class | Veterinary |
| ATC | |
| AHFS | |
| Regulator record | Health Canada DPD entry · Product monograph |
Xylazine Hydrochloride registered in other markets
6 registrations of the same molecule in 2 national registries outside Canada. Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| Malaysia | Chanazine 10% w/v Solution for Injection | KM Vet Pharm Sdn. Bhd. | Veterinary | PRODUCT APPROVED | NPRA | |
| Malaysia | Chanazine 2% w/v Solution for Injection. | KM Vet Pharm Sdn. Bhd. | Veterinary | PRODUCT APPROVED | NPRA | |
| United States | Xylazine Hydrochloride | Syn-Tech Chem. & Pharm. Co., Ltd. | Powder | FDA NDC | ||
| United States | Xylazine Hydrochloride | Syn-Tech Chem. & Pharm. Co., Ltd. | Powder | FDA NDC | ||
| United States | Xylazine Hydrochloride | Alivira Animal Health Limited | Powder | FDA NDC | ||
| United States | Xylazine Hydrochloride | Elanco US Inc. | Injection | FDA NDC |
See every manufacturer of Xylazine Hydrochloride worldwide →
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Rompun Inj 20mg/mL (DIN 00408972) marketed in Canada?
No. Health Canada lists DIN 00408972 as Cancelled Post Market as of 09 Sep 1996.
Who holds the Canadian licence for this product?
Bayvet, Division Of Chemagro Ltd. is the company of record in the Health Canada Drug Product Database.
Is Xylazine Hydrochloride registered outside Canada?
Yes — Nexara Health has matched 6 registrations in 2 other markets (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 00408972, status date 1996-09-09; national medicine registries: FDA NDC, NPRA. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 00408972, status date 1996-09-09; national medicine registries: FDA NDC, NPRA.
Health Canada Drug Product Database (DPD), DIN 00408972, status date 1996-09-09; national medicine registries: FDA NDC, NPRA. Last reviewed 2026-09-17. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.